Published in BMC Womens Health on February 26, 2007
Health related quality of life after combined hormone replacement therapy: randomised controlled trial. BMJ (2008) 3.56
Menopausal hormone therapy and breast cancer: what is the true size of the increased risk? Br J Cancer (2016) 1.47
The Health Informatics Trial Enhancement Project (HITE): Using routinely collected primary care data to identify potential participants for a depression trial. Trials (2010) 1.40
Gender and sex hormones in multiple sclerosis pathology and therapy. Front Biosci (Landmark Ed) (2009) 0.95
Seminars may increase recruitment to randomised controlled trials: lessons learned from WISDOM. Trials (2008) 0.93
Hormone-dependent aging problems in women. Yonsei Med J (2008) 0.82
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
EuroQol--a new facility for the measurement of health-related quality of life. Health Policy (1990) 59.70
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol (1988) 35.68
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials (1998) 20.39
Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet (2003) 18.24
Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med (1992) 12.89
Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med (1991) 8.66
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet (1996) 7.10
A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med (2000) 5.17
Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 4.96
Effects of estrogen plus progestin on health-related quality of life. N Engl J Med (2003) 4.83
The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum (1995) 3.93
A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med (2001) 3.86
Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med (1991) 3.53
A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS. BMJ (1996) 3.19
Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med (2004) 3.12
Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med (1987) 3.00
Risk of venous thromboembolism in users of hormone replacement therapy. Lancet (1996) 2.92
A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology (1997) 2.30
Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework. BMJ (1991) 2.02
Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet (1996) 1.78
Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol (1995) 1.60
Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet (1996) 1.58
Hormone replacement therapy and risk of venous thromboembolism: population based case-control study. BMJ (1997) 1.55
Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study. Ann Intern Med (2001) 1.44
Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Study of Osteoporotic Fractures Research Group. Arch Intern Med (1996) 1.42
Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol (1996) 1.39
Clinimetric properties of the AUSCAN Osteoarthritis Hand Index: an evaluation of reliability, validity and responsiveness. Osteoarthritis Cartilage (2002) 1.33
Development of a new type of global quality of life scale, and comparison of performance and preference for 12 global scales. Qual Life Res (1996) 1.25
Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen. Am J Med (1991) 1.24
Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol (1992) 1.14
Hormone replacement therapy and cardiovascular disease. Br Med Bull (1992) 1.13
Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET). Thromb Haemost (2000) 1.03
Estrogen replacement therapy and risk of epithelial ovarian cancer. Gynecol Oncol (1996) 1.02
WISDOM: history and early demise - was it inevitable? Climacteric (2002) 0.97
Effects of estrogen use on lens transmittance in postmenopausal women. Ophthalmology (1997) 0.97
Review of epidemiologic studies of endometrial cancer and exogenous estrogen. Obstet Gynecol (1979) 0.96
The association between estrogen status and alveolar bone density changes in postmenopausal women with a history of periodontitis. J Periodontol (1997) 0.95
Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer. Br J Cancer (1996) 0.94
Prevalence of dementia in users of hormone replacement therapy as defined by prescription data. J Gerontol A Biol Sci Med Sci (2002) 0.93
Case-control study of venous thromboembolism risk in users of hormone replacement therapy. Lancet (1996) 0.90
Menopausal hormone use and colorectal cancer in Saskatchewan: a record linkage cohort study. Cancer Epidemiol Biomarkers Prev (1995) 0.90
The benefits of estrogen replacement therapy on oral health. The Leisure World cohort. Arch Intern Med (1995) 0.89
Randomised controlled trials and retrospective controls. Br Med J (1980) 0.88
Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study. Trans Am Ophthalmol Soc (1994) 0.86
Sudden sensorineural deafness and hormone replacement therapy. J Laryngol Otol (1996) 0.82
WHI, WHI, WHI? Climacteric (2004) 0.78
Hormone replacement therapy and breast cancer: an overview. Br J Obstet Gynaecol (1996) 0.77
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet (2010) 13.13
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet (2010) 11.00
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet (2012) 4.85
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63
Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma. N Engl J Med (2003) 4.46
Health related quality of life after combined hormone replacement therapy: randomised controlled trial. BMJ (2008) 3.56
Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study. BMJ (2007) 1.71
Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur Heart J (2007) 1.68
Recent respiratory infection and risk of venous thromboembolism: case-control study through a general practice database. Int J Epidemiol (2011) 1.09
Circulating levels of coagulation and inflammation markers and cancer risks: individual participant analysis of data from three long-term cohorts. Int J Epidemiol (2010) 0.94
Long-term association of routine blood count (Coulter) variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I). Int J Epidemiol (2009) 0.78
Low-intensity warfarin reduces thrombin generation and fibrin turnover, but not low-grade inflammation, in men at risk of myocardial infarction. Br J Haematol (2004) 0.77
Antithrombotic treatment and the incidence of angina pectoris. Arch Intern Med (2002) 0.77
Developing service provision for patients in primary care. Nurs Stand (2007) 0.75
Cumulative flying time and risk of venous thromboembolism. Br J Haematol (2011) 0.75
REPEATED MEASUREMENTS OF BLOOD PRESSURE AND CHOLESTEROL IMPROVES CARDIOVASCULAR DISEASE RISK PREDICTION: AN INDIVIDUAL-PARTICIPANT-DATA META-ANALYSIS. Am J Epidemiol (2017) 0.75